Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -440,667 | 681,313 | -96,692 | -153,524 | -81,177 |
| Depreciation Amortization | 1,762 | 10,870 | 14,741 | 15,351 | 12,855 |
| Accounts receivable | 6,411 | -25,505 | 10,664 | 4,269 | -16,340 |
| Accounts payable and accrued liabilities | 12,967 | 971 | 2,074 | 518 | -412 |
| Other Working Capital | 21,688 | -39,006 | -37,616 | 7,930 | -34,705 |
| Other Operating Activity | 69,158 | 89,571 | 26,415 | 8,432 | 46,696 |
| Operating Cash Flow | $-328,681 | $718,214 | $-80,414 | $-117,024 | $-73,083 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26,285 | -11,606 | -9,676 | -6,392 | -11,195 |
| Purchase Of Investment | -1,380,865 | -2,271,250 | -404,425 | -334,659 | -297,608 |
| Sale Of Investment | 1,614,036 | 902,920 | 385,292 | 258,651 | 269,467 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 25,000 |
| Investing Cash Flow | $206,886 | $-1,379,936 | $-28,809 | $-82,400 | $-14,336 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 241,262 |
| Debt Repayment | N/A | N/A | -5,131 | -5,945 | -142,687 |
| Common Stock Issued | 23,355 | 851,966 | 59,522 | 209,563 | 32,208 |
| Financing Cash Flow | $23,355 | $851,966 | $54,391 | $203,618 | $130,783 |
| Exchange Rate Effect | -102 | -101 | -46 | -124 | -159 |
| Beginning Cash Position | 194,905 | 4,762 | 59,640 | 55,570 | 12,365 |
| End Cash Position | 96,363 | 194,905 | 4,762 | 59,640 | 55,570 |
| Net Cash Flow | $-98,542 | $190,143 | $-54,878 | $4,070 | $43,205 |
| Free Cash Flow | |||||
| Operating Cash Flow | -328,681 | 718,214 | -80,414 | -117,024 | -73,083 |
| Capital Expenditure | -26,285 | -14,239 | -9,676 | -6,392 | -11,195 |
| Free Cash Flow | -354,966 | 703,975 | -90,090 | -123,416 | -84,278 |